DI CESARE, ANTONELLA
 Distribuzione geografica
Continente #
AS - Asia 628
NA - Nord America 478
EU - Europa 385
SA - Sud America 47
AF - Africa 22
OC - Oceania 8
Totale 1.568
Nazione #
US - Stati Uniti d'America 454
CN - Cina 231
SG - Singapore 158
DE - Germania 113
IT - Italia 82
RU - Federazione Russa 79
KR - Corea 54
VN - Vietnam 53
HK - Hong Kong 50
FI - Finlandia 48
BR - Brasile 34
JP - Giappone 21
BD - Bangladesh 19
FR - Francia 18
IN - India 12
CA - Canada 10
IE - Irlanda 10
AU - Australia 7
NL - Olanda 7
GB - Regno Unito 6
KE - Kenya 6
MX - Messico 6
SE - Svezia 6
DK - Danimarca 5
TR - Turchia 5
JO - Giordania 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
JM - Giamaica 3
NG - Nigeria 3
UZ - Uzbekistan 3
VE - Venezuela 3
BJ - Benin 2
CH - Svizzera 2
DZ - Algeria 2
EG - Egitto 2
ES - Italia 2
ID - Indonesia 2
IL - Israele 2
KG - Kirghizistan 2
NP - Nepal 2
PK - Pakistan 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
ZA - Sudafrica 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ET - Etiopia 1
GH - Ghana 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RO - Romania 1
SV - El Salvador 1
TN - Tunisia 1
UY - Uruguay 1
Totale 1.568
Città #
Singapore 112
Ashburn 109
Munich 107
Hefei 76
Seoul 53
Hong Kong 47
Helsinki 39
Santa Clara 38
San Jose 33
The Dalles 29
Florence 22
Tokyo 19
Beijing 18
Council Bluffs 18
Rome 18
Chandler 17
Ho Chi Minh City 15
Buffalo 14
Seattle 14
Fairfield 11
Dublin 10
Los Angeles 10
Hanoi 8
Milan 8
Shenzhen 8
Woodbridge 8
Kent 7
Lauterbourg 7
Bengaluru 6
Dearborn 6
Wilmington 6
Dallas 5
New York 5
Altamura 4
Jyväskylä 4
Lawrence 4
Nairobi 4
Tianjin 4
Valby 4
Abuja 3
Amsterdam 3
Asunción 3
Brooklyn 3
Frankfurt am Main 3
Haiphong 3
Houston 3
Melbourne 3
Palermo 3
Paris 3
San Diego 3
Shanghai 3
São Paulo 3
Tashkent 3
Toronto 3
Turku 3
Ann Arbor 2
Atlanta 2
Bakersfield 2
Bern 2
Brisbane 2
Bình Phước 2
Cambridge 2
Chennai 2
Chicago 2
Clifton 2
Cotonou 2
Hillsboro 2
Jeddah 2
Kingston 2
London 2
Macaé 2
Maracaibo 2
Mumbai 2
Orem 2
Phủ Từ Sơn 2
Princeton 2
Stockholm 2
São Leopoldo 2
'Ain Deheb 1
Abu Dhabi 1
Abū Kabīr 1
Acapulco de Juárez 1
Accra 1
Acerra 1
Addis Ababa 1
Almaty 1
Amman 1
Arad 1
Araçatuba 1
Auckland 1
Bahawalpur 1
Barra Mansa 1
Bel Air 1
Bishkek 1
Boston 1
Brasília 1
Bridgetown 1
Bursa 1
Bảo Lộc 1
Bắc Ninh 1
Totale 1.043
Nome #
Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines 314
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa 198
Polygenic Score: A Tool for Evaluating the Genetic Background of Sporadic Hidradenitis Suppurativa 156
Anti-Interleukin-17s for successful management of pustular psoriasis 107
Estimation of patients with psoriasis potentially eligible and currently untreated with biological drugs in Italy 97
Discoid lupus erythematosus affecting the scalp 93
Therapy of PsO in Special Subsets of Patients 87
Effects on Lipid Profile after One Year of Apremilast Therapy in Patients with Psoriasis: A Monocentric Experience 74
Psoriasis Flare in a Liver Transplant Patient: A Case Report of a Successful Treatment With Apremilast 73
Identification of clinical features affecting diagnostic delay in paediatric hidradenitis suppurativa: results from a multicentre observational study 61
Hidradenitis Suppurativa: The Influence of Gender, the Importance of Trigger Factors and the Implications for Patient Habits 59
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study 39
Psoriasis severity, comorbidity burden, and biologic therapy: a multicenter observational study using the Charlson Comorbidity Index 25
Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation 24
Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas 23
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics 22
Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study 22
Risankizumab in very elderly patients in real-world practice 18
Drug survival, long-term safety and efficacy of anti-TNF-alpha biosimilars: a monocentric retrospective study 18
Risankizumab in Oncologic Patients With Psoriasis: A Case Series 16
Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study 15
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study 14
Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa 13
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre study 11
Fibrillar pattern as ultrasonographic progression biomarker of hidradenitis suppurativa 8
Targeting IL-17A for the treatment of pustular psoriasis: a comprehensive review 7
Totale 1.594
Categoria #
all - tutte 3.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 2 0
2021/202218 2 0 2 1 0 2 0 4 0 0 3 4
2022/202355 2 13 2 4 7 6 5 1 6 0 3 6
2023/202413 1 0 3 0 0 1 0 5 0 1 0 2
2024/2025391 5 12 8 16 33 58 76 53 60 7 23 40
2025/20261.051 112 130 147 62 95 27 85 81 153 95 64 0
Totale 1.594